Status:
COMPLETED
Immuno-humoral Rejection Markers in Pulmonary Transplant
Lead Sponsor:
Hopital Foch
Conditions:
Lung Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Open multicentric prospective study performed on pulmonary transplanted patients to detect the values of different diagnostic markers for immuno- humoral reaction and their roles in the humoral reject...
Eligibility Criteria
Inclusion
- Both genders, more than 18 years of age.
- Patients with or without Cystic fibrosis
- Patients with no previous unilateral or bilateral pulmonary transplant or cardiopulmonary transplant
- Patients with no current other disease can affect, in short term, the process or prognosis of the transplant
- Patients had given his agreement to be enrolled in the study
Exclusion
- Patient less than 18 year-old
- Patient had previous organ transplant
- Pregnant and/or lactating women
- Female subject in reproductive age does not use effective contraceptive methode
- Alcoholisms or neuropsychosis, conditions that affect the good comprehension of the study
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01791166
Start Date
February 1 2011
End Date
July 1 2014
Last Update
September 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital FOCH
Suresnes, Île-de-France Region, France, 92150